ESC 365 - 12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial

ESC Premium Access

12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial

Session: Chronic coronary syndromes: pathophysiology, treatment, and prognosis

Topic: Prevention

Speaker: Doctor M. Nidorf (Perth, AU)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

About the speaker

Doctor Mark Nidorf

GenesisCare, Perth (Australia)

3 presentations

0 follower

4 more presentations in this session

Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry

Speaker: Doctor M. Kerneis (Paris, FR)

Association of elevated lipoprotein(a) level and monocyte subsets with the severity of coronary atherosclerosis

Speaker: Miss A. Filatova (Moscow, RU)

Sex-dependent impact of coronary microvascular dysfunction on long-term clinical outcomes in patients with no-obstructive coronary artery disease

Speaker: Doctor T. Toya (Rochester, US)

Detectable troponin below the 99th percentile predicts survival in patients with cardiovascular disease

Speaker: Doctor L. Michel (Essen, DE)

Access the full session

Chronic coronary syndromes: pathophysiology, treatment, and prognosis

Speakers: Doctor M. Nidorf, Doctor M. Kerneis, Miss A. Filatova, Doctor T. Toya, Doctor L. Michel

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources